Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Retatrutide is an investigational triple agonist peptide being developed by Eli Lilly, designed to simultaneously target GLP-1, GIP, and glucagon receptors a mechanism that distinguishes it from currently approved agents such as semaglutide and tirzepatide
It has an order, it has a self order to it
Semaglutide Overview Top Benefits: Appetite reduction, improved blood sugar control, steady weekly weight loss Form: Prescription injectable (compounded) Plan Options: 1-month, 3-month, 6-month, 12-month plans Average Cost: $149.97/month Side Effects: Nausea, slowed digestion, mild fatigue, constipation Dangers: Risk of GI distress, pancreatitis (rare), contraindicated for certain thyroid conditions Best Support Stack: B-12, electrolytes, high-protein diet Men/Women: Suitable for adults under medical evaluation Book your consultation through Enhanced Clinics to start
Many people considering compounded semaglutide ask whether they could modify injection frequency to twice weekly for faster results or other reasons
A primary care physician is a good starting point
Some data suggest that VHT and VHE may be promoted by carnitine deficiency
